During the past decade, Ospedale Giovanni Bosco, Sc Cardiologia conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale Giovanni Bosco, Sc Cardiologia" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator and "Centro Servizi ANMCO S.r.l." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Ospedale Giovanni Bosco, Sc Cardiologia" are "Atrial Fibrillation" (2 trials), "Acute Coronary Syndrome" (1 trials), "Acute Coronary Syndromes" (1 trials), "Cancer" (1 trials) and "Heart Failure" (1 trials). Many other conditions were trialed in "Ospedale Giovanni Bosco, Sc Cardiologia" in a lesser frequency.

Most popular intervention types in "Ospedale Giovanni Bosco, Sc Cardiologia" are "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Acute coronary syndrome and PCI and AF" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale Giovanni Bosco, Sc Cardiologia" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Ospedale Giovanni Bosco, Sc Cardiologia". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Ospedale Giovanni Bosco, Sc Cardiologia, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale Giovanni Bosco, Sc Cardiologia, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".